Home › Funds › BFC Planning, Inc. › ADPT
BFC Planning, Inc. position in ADPT
ADAPTIVE BIOTECHNOLOGIES COR · Health Care
BFC Planning, Inc. reported holding 465,189 shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR) in its Q3 2026 13F filing — a position valued at US$13.4M, representing 0.56% of its reported portfolio and ranking #30 among its reported holdings. BFC Planning, Inc. has disclosed ADPT holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How BFC Planning, Inc.'s ADPT position evolved
BFC Planning, Inc. first disclosed a stake in ADPT in Q1 2026 at 35 shares (US$0K). The position peaked in Q3 2026 at 465,189 shares, worth US$13.4M. Across 3 filings, BFC Planning, Inc. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 465,189 shares valued at US$13.4M — an increase of 465,154 shares quarter over quarter.. Notable position changes include a 1329011% increase in Q3 2026 (shares rose 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 35 | $486 | New |
| Q2 2026 | 35 | $751 | Hold |
| Q3 2026 | 465.19K | $13.44M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ADPT and 13F data
ADPT (ADAPTIVE BIOTECHNOLOGIES COR) is a Health Care company. 58 other funds we track also report a position in ADPT — the largest reported positions include Viking Global Investors (US$643.4M), VIKING GLOBAL INVESTORS LP (US$643.4M), Aristotle Atlantic Partners, LLC (US$39.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ADPT
- Viking Global Investors 29.99M sh · $643.37M · Q2 2026
- VIKING GLOBAL INVESTORS LP 29.99M sh · $643.37M · Q2 2026
- Aristotle Atlantic Partners, LLC 1.84M sh · $39.44M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.22M sh · $26.11M · Q2 2026
- Blue Water Life Science Advisors, LP 1.01M sh · $21.67M · Q2 2026
- Granite Investment Partners, LLC 628.10K sh · $18.15M · Q3 2026
- NEXT CENTURY GROWTH INVESTORS LLC 622.89K sh · $18.00M · Q3 2026
- Hillsdale Investment Management Inc. 551.35K sh · $15.93M · Q3 2026
More on BFC Planning, Inc.
FAQ
How long has BFC Planning, Inc. held ADPT?
BFC Planning, Inc. has disclosed ADPT holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is BFC Planning, Inc.'s current position in ADPT?
As of Q3 2026, BFC Planning, Inc. holds 465.19K shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR), valued at $13.44M, representing 0.56% of its reported portfolio and ranking #30.
Has BFC Planning, Inc. been buying or selling ADPT?
In the latest 13F filing (Q3 2026), BFC Planning, Inc. increased its position in ADPT. The position peaked in Q3 2026 at 465.19K shares.
Which other funds hold ADPT?
Other major institutional holders of ADPT include Viking Global Investors, VIKING GLOBAL INVESTORS LP, Aristotle Atlantic Partners, LLC, among 58 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.